Portal Diabetes, Inc

At Portal Diabetes (PKA PhysioLogic Devices), we are committed to transforming the treatment of insulin-requiring diabetes. Our technology automatically controls glucose through a state-of-the-art implantable insulin pump paired with a glucose sensor. Normal insulin and glucose physiology is restored because the insulin is delivered deep in the abdomen for uptake by the liver. Our new approach fully automatic and implantable gives people true freedom from the heavy burden of insulin therapy

Portal diabetes, inc operates in the Medical equipment manufacturing industry.

Portal diabetes, inc's revenue is 11m - 100m

Portal diabetes, inc has 11 - 50 employees.